New drug introductions are a key to growth for pharmaceutical firms. However not all innovations are the same and they may have differential effects that vary by firm size. We use quarterly sales data on UK pharmaceuticals in a dynamic panel model to estimate the impact of product (new drugs)...

While there is an extensive literature on the relationship between market competition and innovation at the aggregate level, there are far fewer case-specific accounts of this relationship, particularly on the effects of specific competition policy interventions on innovation. The objective of...

This is an ex-post evaluation of how innovation changed following mergers and subsequent policy interventions, using an industry case study involving the 5-to-3 consolidation of three related mergers in the worldwide hard disk drive (HDD) industry, in 2011/12. Unlike most previous empirical...